ロード中...
Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice
Adenoviral (Ad) vectors represent promising vaccine platforms for infectious disease. To overcome pre-existing immunity to commonly used human adenovirus serotype 5 (Ad5), vectors based on rare species or non-human Ads are being developed. However, these vectors often exhibit reduced potency compare...
保存先:
| 出版年: | Mol Ther Methods Clin Dev |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Gene & Cell Therapy
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6953706/ https://ncbi.nlm.nih.gov/pubmed/31934599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2019.12.003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|